Gainers
-
Aemetis Inc (NASDAQ: AMTX) shares jumped 62
percent to $1.05 following news that the company has completed operation of cellulosic ethanol integrated demonstration unit.
-
Amedica Corporation (NASDAQ: AMDA) shares climbed
34.5 percent to $2.69 after the company reported the FDA clearance of Valeo C+CsC with Lumen Interbody Fusion Device.
-
CommerceHub Inc (NASDAQ: CHUBK) surged 28.5
percent to $22.44 as the company agreed to be acquired by GTCR and Sycamore Partners for $22.75 per share in cash.
-
CommerceHub Inc (NASDAQ: CHUBA) gained 23.15
percent to $22.50 as the company agreed to be acquired by GTCR and Sycamore Partners for $22.75 per share in cash.
-
Baozun Inc (ADR) (NASDAQ: BZUN) jumped 20.8
percent to $44.43 after reporting Q4 results.
-
ACM Research Inc (NASDAQ: ACMR) rose 18 percent
to $9.27.
-
Ameresco Inc (NYSE: AMRC) shares surged 16.2
percent to $9.70 following upbeat Q4 results.
-
Synthesis Energy Systems, Inc. (NASDAQ: SES)
climbed 15.7 percent to $3.25.
-
Par Pacific Holdings, Inc. (NYSE: PARR) rose 13.2
percent to $19.58 after reporting Q4 results.
-
Analogic Corporation (NASDAQ: ALOG) shares gained
11 percent to $94.30 following strong Q2 results.
-
Sunshine Heart Inc (NASDAQ: CHFS) shares rose 11
percent to $3.57.
-
Ciena Corporation (NYSE: CIEN) surged 10.5 percent
to $25.81 after the company reported better-than-expected results for its first quarter.
-
Caladrius Biosciences Inc (NASDAQ: CLBS) rose
10.1 percent to $5.54. Caladrius Biosciences acquired a license to a late stage CD34+ cell therapy program for the treatment of
refractory angina from Shire.
-
Quanex Building Products Corporation (NYSE: NX)
jumped 9.7 percent to $19.15 following upbeat quarterly results.
-
Frontline Ltd. (NYSE: FRO) gained 9.3 percent to
$4.43.
-
Beyondspring Inc (NASDAQ: BYSI) shares rose 9.1
percent to $29.30.
-
DURECT Corporation (NASDAQ: DRRX) surged 9
percent to $1.63. H.C. Wainwright upgraded DURECT from Neutral to Buy.
-
Baytex Energy Corp (USA) (NYSE: BTE) gained 6.5
percent to $2.92 after reporting 2017 results.
-
Enphase Energy Inc (NASDAQ: ENPH) climbed 5.7
percent to $3.92 after gaining 8.16 percent on Monday
-
Tarena International Inc(ADR) (NASDAQ: TEDU)
gained 4 percent to $12.96 after the company reported Q4 results and declared a special dividend of $0.12 per share.
Check out these big penny stock gainers and
losers
Losers
-
GlycoMimetics Inc (NASDAQ: GLYC) dropped 20
percent to $18.26 after reporting the design of phase 3 trial of GMI-1271 in relapsed/refractory AML. GlycoMimetics reported a
Q4 loss of $0.27 per share.
-
TransAct Technologies Incorporated (NASDAQ: TACT)
shares declined 15.5 percent to $11.57 following a fourth quarter earnings and sales miss. The company also announced a $5
million share buyback plan.
-
Marinus Pharmaceuticals Inc (NASDAQ: MRNS) shares
fell 13 percent to $4.57. Marinus Pharma reported a FY 2017 loss of $0.80 per share.
-
Innovate Biopharmaceuticals Inc (NASDAQ: INNT)
shares dipped 13.9 percent to $14.90 after rising 82.49 percent on Monday.
-
Infinity Pharmaceuticals Inc. (NASDAQ: INFI)
shares dipped 13.3 percent to $2.36 after rising 31.40 percent on Monday.
-
Freshpet Inc (NASDAQ: FRPT) declined 11.8 percent
to $18.15 following Q4 earnings miss and soft FY18 sales guidance.
-
Orchids Paper Products Company (NYSE: TIS) shares
fell 11.4 percent to $9.53 after the company reported downbeat quarterly results.
-
YY Inc (ADR) (NASDAQ: YY) dropped 10 percent to
$122.14 following quarterly results.
-
iFresh Inc (NASDAQ: IFMK) slipped 9.5 percent to
$8.91.
-
Obalon Therapeutics Inc (NASDAQ: OBLN) shares
tumbled 9 percent to $3.65.
-
Ares Management LP (NYSE: ARES) fell 8.3 percent to
$23.15 following news of 5 million share offering by the company and 10 million share offering by strategic investor.
-
Bravo Brio Restaurant Group, Inc. (NASDAQ: BBRG)
dropped 8.2 percent to $3.35.
-
Gogo Inc (NASDAQ: GOGO) shares fell 7 percent to
$8.74. Gogo named Oakleigh Thorne as CEO.
-
Insys Therapeutics Inc (NASDAQ: INSY) shares
slipped 6.6 percent to $7.53 after gaining 3.73 percent on Monday.
-
Fate Therapeutics Inc (NASDAQ: FATE) tumbled 6.4
percent to $12.90. Fate Therapeutics reported a Q4 loss of $0.29 per share.
-
Vericel Corp (NASDAQ: VCEL) fell 5.5 percent to
$11.20 after climbing 41.92 percent on Monday.
-
Ascena Retail Group Inc (NASDAQ: ASNA) shares
slipped 5.4 percent to $2.29 after the company posted a wider-than-expected loss for its second quarter and issued weak
third-quarter earnings guidance.
-
Target Corporation (NYSE: TGT) shares fell 3.2
percent to $72.76 after the company reported downbeat earnings for its fourth quarter.
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.